Literature DB >> 7914359

Opposing effects of transforming growth factor-beta 1 on glutamate neurotoxicity.

J H Prehn1, J Krieglstein.   

Abstract

Activation of microglia has been emphasized as a critical step in the pathophysiology of degenerative and inflammatory processes of the CNS. Activated microglia release low molecular weight compounds, such as excitatory amino acids, that are directly toxic to neurons. Here we demonstrate that a microglia-derived cytokine, transforming growth factor-beta 1, directly alters the susceptibility of neurons to glutamate-induced cell damage. Transforming growth factor-beta 1 acts as a neuroprotectant following short-term exposure to glutamate, whereas, following chronic exposure to glutamate, similar concentrations of transforming growth factor-beta 1 actually potentiate excitotoxic cell death. This complex interaction may play an important role in determining the extent of local tissue damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914359     DOI: 10.1016/0306-4522(94)90198-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

Review 1.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

2.  Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.

Authors:  M E Harris-White; T Chu; Z Balverde; J J Sigel; K C Flanders; S A Frautschy
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 3.  TGF-β Family Signaling in Neural and Neuronal Differentiation, Development, and Function.

Authors:  Emily A Meyers; John A Kessler
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 4.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus.

Authors:  S E Tsirka; A D Rogove; T H Bugge; J L Degen; S Strickland
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 6.  Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.

Authors:  Alon Friedman; Daniela Kaufer; Uwe Heinemann
Journal:  Epilepsy Res       Date:  2009-04-11       Impact factor: 3.045

7.  Oxidative stress and microglial cells in Parkinson's disease.

Authors:  Lynda J Peterson; Patrick M Flood
Journal:  Mediators Inflamm       Date:  2012-03-22       Impact factor: 4.711

8.  TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.

Authors:  Hans-Georg König; Donat Kögel; Abdelhaq Rami; Jochen H M Prehn
Journal:  J Cell Biol       Date:  2005-03-21       Impact factor: 10.539

9.  Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice.

Authors:  María González-Núñez; Adela S Riolobos; Orlando Castellano; Isabel Fuentes-Calvo; María de los Ángeles Sevilla; Bárbara Oujo; Miguel Pericacho; Ignacio Cruz-Gonzalez; Fernando Pérez-Barriocanal; Peter ten Dijke; Jose M López-Novoa
Journal:  Dis Model Mech       Date:  2015-09-17       Impact factor: 5.758

10.  TGFβRI antagonist inhibits HIV-1 Nef-induced CC chemokine family ligand 2 (CCL2) in the brain and prevents spatial learning impairment.

Authors:  Gladys Chompre; Neysha Martinez-Orengo; Myrella Cruz; James T Porter; Richard J Noel
Journal:  J Neuroinflammation       Date:  2019-12-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.